June 29, 2017 12:44 AM ET


Company Overview of IDM Pharma, Inc.

Company Overview

IDM Pharma, Inc. develops cancer products for destroying cancer cells by activating the immune system and preventing tumor recurrence by triggering a specific adaptive immune response. The company’s products include L-MTP-PE, known as MEPACT, a liposomal muramyl-tripeptide phosphatidylethanol- amine, for the treatment of osteosarcoma; BEXIDEM, a Phase II clinical trial completed product for the treatment of bladder cancer; UVIDEM, which is in Phase II clinical trials for the treatment of melanoma; IDM-2101 that is in Phase II clinical trials for the treatment of non-small cell lung cancer; and COLLIDEM, which is in Phase I/II clinical trials for the treatment of colorectal cancer. It has col...

9 Parker

Suite 100

Irvine, CA 92618

United States

Founded in 1987

15 Employees





Key Executives for IDM Pharma, Inc.

President, Secretary, Treasurer, and Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IDM Pharma, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.